The Intermed Group's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.

The Intermed Group

Latest quarter: No record; Q3 2026 · 0 reports
Last 12 months: $0; Last 4 quarters
vs last quarter: No record; Q3 2026 against the quarter before
First report: Q4 2022; The first quarter a report named it

Lobbying by quarter

The Intermed Group lobbying by quarter
Quarter	Amount	Reports
Q4 2022	$0	1
Q1 2023	$0	1
Q2 2023	$0	1
Q3 2023	$7,500	1
Q4 2023	$7,500	1
Q1 2024	$0	1
Q2 2024	$0	1
Q3 2024	$0	0
Q4 2024	$0	0
Q1 2025	$0	0
Q2 2025	$0	0
Q3 2025	$0	0
Q4 2025	$0	0
Q1 2026	$0	0
Q2 2026	$0	0
Q3 2026	$0	0

By issue

Health issues$15K · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

Federal Trade Commission (FTC)7 reports
Food & Drug Administration (FDA)7 reports
HOUSE OF REPRESENTATIVES7 reports
SENATE7 reports

Firms it paid

Firm
Hall, Render, Killian, Heath & Lyman, P.C.	$15K	7 quarters

Former officials lobbying for it

	Former position	Firm
ANDREW COATS	Legislative Assistant, Rep. Mark Souder.	Hall, Render, Killian, Heath & Lyman, P.C.	Q2 2024
JOHN FRANCIS WILLIAMS iii	Press Secretary, House Committee on Government Reform and Oversight; Press Secretary, Rep. Dan Burton.	Hall, Render, Killian, Heath & Lyman, P.C.	Q2 2024

Lobbying reports

	Filed by		Issues
24/07/09for Q2 2024	Hall, Render, Killian, Heath & Lyman, P.C.	Under $5,000	Health issues
24/04/09for Q1 2024	Hall, Render, Killian, Heath & Lyman, P.C.	Under $5,000	Health issues
24/01/10for Q4 2023	Hall, Render, Killian, Heath & Lyman, P.C.	$7,500	Health issues
23/10/04for Q3 2023	Hall, Render, Killian, Heath & Lyman, P.C.	$7,500	Health issues
23/07/18for Q2 2023	Hall, Render, Killian, Heath & Lyman, P.C.	Under $5,000	Health issues
23/04/11for Q1 2023	Hall, Render, Killian, Heath & Lyman, P.C.	Under $5,000	Health issues
23/01/13for Q4 2022	Hall, Render, Killian, Heath & Lyman, P.C.	Under $5,000	Health issues